Literature DB >> 15760082

In vivo release kinetics of octreotide acetate from experimental polymeric microsphere formulations using oil/water and oil/oil processes.

Santos B Murty1, Qui Wei, B C Thanoo, Patrick P DeLuca.   

Abstract

The purpose of the present study was to characterize the in vivo release kinetics of octreotide acetate from microsphere formulations designed to minimize peptide acylation and improve drug stability. Microspheres were prepared by a conventional oil/water (o/w) method or an experimental oil/oil (o/o) dispersion technique. The dosage forms were administered subcutaneously to a rat animal model, and serum samples were analyzed by radioimmunoassay over a 2-month period. An averaged kinetic profile from each treatment group, as a result, was treated with fractional differential equations. The results indicated that poly(l-lactide) microspheres prepared by the o/o dispersion technique provided lower area under the curve (AUC) values during the initial diffusion-controlled release phase, 7.79 ngxd/mL, versus 75.8 ngxd/mL for the o/w batch. During the subsequent erosion-controlled release phase, on the other hand, the o/o technique yielded higher AUC values, 123 ngxd/mL, versus 42.2 ngxd/mL for the o/w batch. The differences observed between the 2 techniques were attributed to the site of drug incorporation during the manufacturing process, given that microspheres contain both porous hydrophilic channels and dense hydrophobic matrix regions. An o/o dispersion technique was therefore expected to produce microspheres with lower incorporation in the aqueous channels, which are responsible for diffusion-mediated drug release.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15760082      PMCID: PMC2750271          DOI: 10.1208/pt050349

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  13 in total

1.  Effect of processing parameters on the properties of peptide-containing PLGA microspheres.

Authors:  R Jeyanthi; R C Mehta; B C Thanoo; P P DeLuca
Journal:  J Microencapsul       Date:  1997 Mar-Apr       Impact factor: 3.142

2.  Disposition of sandostatin, a new synthetic somatostatin analogue, in rats.

Authors:  M Lemaire; M Azria; R Dannecker; P Marbach; A Schweitzer; G Maurer
Journal:  Drug Metab Dispos       Date:  1989 Nov-Dec       Impact factor: 3.922

3.  Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres.

Authors:  J W Kostanski; B C Thanoo; P P DeLuca
Journal:  Pharm Dev Technol       Date:  2000       Impact factor: 3.133

4.  Immunological effects of aspirin anhydride, a contaminant of commercial acetylsalicylic acid preparations.

Authors:  A L De Weck
Journal:  Int Arch Allergy Appl Immunol       Date:  1971

5.  Pharmacokinetic analysis of concentration data of drugs with irregular absorption profiles using multi-fraction absorption models.

Authors:  K Murata; K Noda; K Kohno; M Samejima
Journal:  J Pharm Sci       Date:  1987-02       Impact factor: 3.534

6.  In vivo evaluation of controlled-release products.

Authors:  S S Hwang; W Bayne; F Theeuwes
Journal:  J Pharm Sci       Date:  1993-11       Impact factor: 3.534

7.  Modeling the kinetics of release of octreotide from long-acting formulations injected intramuscularly in rabbits.

Authors:  E Comets; F Mentré; R Kawai; F Nimmerfall; P Marbach; J Vonderscher
Journal:  J Pharm Sci       Date:  2000-09       Impact factor: 3.534

8.  Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions.

Authors:  Santos B Murty; Jack Goodman; B C Thanoo; Patrick P DeLuca
Journal:  AAPS PharmSciTech       Date:  2003-10-13       Impact factor: 3.246

9.  Characterization of biodegradable poly(D,L-lactide-co-glycolide) polymers and microspheres.

Authors:  A G Hausberger; P P DeLuca
Journal:  J Pharm Biomed Anal       Date:  1995-05       Impact factor: 3.935

10.  Radioimmunoassay for octapeptide analogs of somatostatin: measurement of serum levels after administration of long-acting microcapsule formulations.

Authors:  M Mason-Garcia; M Vaccarella; J Horvath; T W Redding; K Groot; P Orsolini; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

View more
  4 in total

1.  Sustained-release delivery of octreotide from biodegradable polymeric microspheres.

Authors:  Yun-Seok Rhee; MinJi Sohn; Byung H Woo; B C Thanoo; Patrick P DeLuca; Heidi M Mansour
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

2.  Formation of acylated growth hormone-releasing peptide-6 by poly(lactide-co-glycolide) and its biological activity.

Authors:  Dong Hee Na; Jeong Eun Lee; Sun Woo Jang; Kang Choon Lee
Journal:  AAPS PharmSciTech       Date:  2007-06-08       Impact factor: 3.246

3.  The solution and solid state stability and excipient compatibility of parthenolide in feverfew.

Authors:  Ping Jin; Shadi Madieh; Larry L Augsburger
Journal:  AAPS PharmSciTech       Date:  2007-12-14       Impact factor: 3.246

4.  Release of a wound-healing agent from PLGA microspheres in a thermosensitive gel.

Authors:  H A Machado; J J Abercrombie; T You; P P Deluca; K P Leung
Journal:  Biomed Res Int       Date:  2013-10-03       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.